We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.3B
AUM Growth
-$819M
Cap. Flow
-$4.1B
Cap. Flow %
-28.74%
Top 10 Hldgs %
17.38%
Holding
669
New
46
Increased
230
Reduced
138
Closed
57

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$85.5M
2
DIS icon
Walt Disney
DIS
+$78.1M
3
ABBV icon
AbbVie
ABBV
+$69.4M
4
HCA icon
HCA Healthcare
HCA
+$65.8M
5
ESRX
Express Scripts Holding Company
ESRX
+$60.5M

Sector Composition

Rank Sector Weight
1 Healthcare 10.59%
2 Technology 9.91%
3 Communication Services 8.97%
4 Industrials 8.5%
5 Financials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFS
176
DELISTED
Discover Financial Services
DFS
$12.4M 0.09%
230,680
-354
-0.2% -$19.3K
ABT icon
177
Abbott
ABT
$180B
$12.3M 0.09%
312,118
+54
+0% +$2.15K
RHT
178
DELISTED
Red Hat Inc
RHT
$12M 0.08%
165,584
-240,393
-59% -$18M
ULTI
179
DELISTED
Ultimate Software Group Inc
ULTI
$11.9M 0.08%
+56,695
New +$11.3M
BMY icon
180
Bristol-Myers Squibb
BMY
$127B
$11.5M 0.08%
156,752
+58
+0% +$4.1K
GS icon
181
Goldman Sachs
GS
$313B
$10.2M 0.07%
68,909
+1,463
+2% +$228K
TCOM icon
182
Trip.com Group
TCOM
$27.5B
$9.83M 0.07%
238,700
-1,695
-0.7% -$73.9K
SPG icon
183
Simon Property Group
SPG
$74.5B
$9.74M 0.07%
44,920
+17
+0% +$3.47K
SO icon
184
Southern Company
SO
$110B
$9.72M 0.07%
181,320
+66
+0% +$3.32K
TXN icon
185
Texas Instruments
TXN
$255B
$9.4M 0.07%
150,088
+50
+0% +$2.97K
SYF icon
186
Synchrony
SYF
$23.7B
$9.27M 0.07%
366,720
+37
+0% +$1.08K
ILMN icon
187
Illumina
ILMN
$29.4B
$9.15M 0.06%
67,038
+4,315
+7% +$613K
PSX icon
188
Phillips 66
PSX
$82.9B
$8.62M 0.06%
108,639
+30
+0% +$2.45K
MON
189
DELISTED
Monsanto Co
MON
$8.61M 0.06%
83,212
-11,969
-13% -$1.19M
AMSG
190
DELISTED
Amsurg Corp
AMSG
$8.26M 0.06%
106,480
-88,340
-45% -$6.83M
ESRX
191
DELISTED
Express Scripts Holding Company
ESRX
$8.21M 0.06%
108,338
-823,459
-88% -$60.5M
ELV icon
192
Elevance Health
ELV
$81.9B
$8.1M 0.06%
61,639
-2,263
-4% -$310K
USB icon
193
US Bancorp
USB
$99.6B
$7.87M 0.06%
195,121
+68
+0% +$2.83K
CHKP icon
194
Check Point Software Technologies
CHKP
$13.3B
$7.85M 0.06%
98,505
-47,475
-33% -$3.97M
COP icon
195
ConocoPhillips
COP
$147B
$7.8M 0.05%
178,960
+192
+0.1% +$8.47K
YUM icon
196
Yum! Brands
YUM
$41B
$7.71M 0.05%
129,255
+12
+0% +$707
AET
197
DELISTED
Aetna Inc
AET
$7.69M 0.05%
62,960
+23
+0% +$2.64K
PRU icon
198
Prudential Financial
PRU
$41.7B
$7.3M 0.05%
102,264
+35
+0% +$2.64K
KMI icon
199
Kinder Morgan
KMI
$73.1B
$7.25M 0.05%
387,101
+75
+0% +$1.34K
BABA icon
200
Alibaba
BABA
$269B
$7.17M 0.05%
90,180
-178,155
-66% -$13.9M

Similar funds

Calamos Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Calamos Advisors held 669 positions worth $14.3B, down 5.4% from $15.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Calamos Advisors withdrew a net $4.1B in Q2 2016, closing 57 positions and reducing 138 holdings. Its most notable exit was HCA Healthcare, an estimated $65.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Calamos Advisors opened a new position in Newell Brands worth $51.9M.

  • Calamos Advisors's largest Q2 2016 buy was Newell Brands: 1,068,110 shares worth $51.9M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $90.5M increase.
  • Calamos Advisors's biggest Q2 2016 reduction was Accenture, cutting an estimated $85.5M.
  • Calamos Advisors fully exited HCA Healthcare in Q2 2016, selling an estimated $65.8M.
  • Calamos Advisors's ten largest holdings make up 17% of its $14.3B portfolio in Q2 2016.
  • Calamos Advisors opened 46 new positions and closed 57 in Q2 2016.
  • Calamos Advisors's portfolio value fell 5.4% quarter-over-quarter to $14.3B.

Based on Calamos Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.